Trial Profile
Phase I, Open-label Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Oct 2013
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 30 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 30 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2011 Actual initiation date (Jul 2011) added as reported by ClinicalTrials.gov.